Study identification

PURI

https://redirect.ema.europa.eu/resource/28093

EU PAS number

EUPAS14060

Study ID

28093

Official title and acronym

Estimating prevalence and incidence of acute myocardial infarction in a set of heterogeneous sources of observational health data collaborating in the EMIF Platform

DARWIN EU® study

No

Study countries

Denmark
Estonia
Italy
Netherlands
Spain
United Kingdom

Study description

The European Medical Information Framework (EMIF) project has the main objective of building an infrastructure for the efficient re-use of existing health care data for epidemiological research. Within the project, the EMIF-Platform represents a federation of heterogeneous sources of health data (e.g. administrative, hospital or primary care databases, disease registries, biobanks). One of the major challenges for the EMIF project is to deal with the different characteristics of the participating data sources in order to facilitate the execution of large multi-national, multi-data source observational studies and generate high quality evidence. For this purpose, a template data derivation procedure was specifically developed. In this proof-of-concept study, the standard procedure will be applied for the identification of patients with acute myocardial infarction (AMI) in a set of heterogeneous sources of observational health data. Validity indices (sensitivity, PPV) of the data source-tailored case-finding algorithms will be estimated from available evidence, and adjusted prevalence and incidence of AMI will be estimated from the participating data sources.

Study status

Ongoing
Research institutions and networks

Institutions

University of Tartu
Estonia
First published:
01/02/2024
InstitutionEducational Institution
IMIM-Hospital del Mar Medical Research Institute and Universitat Pompeu Fabra Barcelona, Spain, The Health Improvement Network, Cegedim Strategic Data Medical Research Ltd London, United Kingdom, Quretec, Software Technology and Applications Competence Center, University of Tartu Tartu, Estonia, Department of Clinical Epidemiology, Aarhus University Hosptial Aarhus, Denmark

Networks

Contact details

Roberto Giuseppe

Primary lead investigator
Study timelines

Date when funding contract was signed

Planned:
Actual:

Study start date

Planned:
Actual:

Date of final study report

Planned:
Sources of funding
Other

More details on funding

EU/EFPIA
Study protocol
Initial protocol
English (180.4 KB - PDF)View document
Updated protocol
English (179.78 KB - PDF)View document
Regulatory

Was the study required by a regulatory body?

No

Is the study required by a Risk Management Plan (RMP)?

Not applicable